Mankind Pharma shares are expected to remain in focus on Wednesday after the pharmaceutical major posted an 8% year-on-year rise in consolidated net profit, which stood at Rs 414 crore in Q3FY26, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results